-
1.发明公开Substituted hexahydro-arylquinolizine derivatives, processes for their preparation and pharmaceutical composition containing them 失效取代Hexahydroarylchinolizinderivate，涉及它们的制备方法和含有它们的药物组合物。
公开(公告)号：EP0214556A1
公开(公告)日：1987-03-18
申请号：EP86111890.9
申请日：1986-08-28
申请人： Merck & Co., Inc.
发明人： Huff, Joel R. , Baldwin, John J. , Vacca, Joseph P. , Guare, James P., Jr. , Sakurai, Yojiro MSD(Japan)Co.Ltd.
IPC分类号： C07D491/147 , C07D495/14 , C07D471/14 , C07D455/06 , C07D513/14 , A61K31/435
CPC分类号： C07D471/14 , C07D455/06 , C07D491/14 , C07D495/14
摘要： Substituted hexahydro arylquinolizines and pharmaceutically acceptable salts thereof are selective α 2 -adranergic receptor antagonists and thereby useful as antidepressants, antihypertensives, ocular antihypertensives, antidiabetics, antiobesity and platelet aggregation inhibitors and modifiers of gastrointestinal motility.
-
2.发明授权Substituted hexahydro-arylquinolizine derivatives, processes for their preparation and pharmaceutical composition containing them 失效取代的四氢呋喃衍生物衍生物，其制备方法和含有它们的药物组合物
公开(公告)号：EP0214556B1
公开(公告)日：1990-11-22
申请号：EP86111890.9
申请日：1986-08-28
申请人： Merck & Co., Inc.
发明人： Huff, Joel R. , Baldwin, John J. , Vacca, Joseph P. , Guare, James P., Jr. , Sakurai, Yojiro MSD(Japan)Co.Ltd.
IPC分类号： C07D491/147 , C07D495/14 , C07D471/14 , C07D455/06 , C07D513/14 , A61K31/435
CPC分类号： C07D471/14 , C07D455/06 , C07D491/14 , C07D495/14
-
搜索结果
2 条记录 (耗时 0.01 秒)
